• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素和泼尼松治疗慢性淋巴细胞白血病患者的纯红细胞再生障碍性贫血

Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia.

作者信息

Chikkappa G, Pasquale D, Zarrabi M H, Weiler R J, Divakara M, Tsan M F

机构信息

Medical Service, Department of Veterans Affairs Medical Centers, Albany, N.Y. 12208.

出版信息

Am J Hematol. 1992 Sep;41(1):5-12. doi: 10.1002/ajh.2830410103.

DOI:10.1002/ajh.2830410103
PMID:1503099
Abstract

We describe the characteristics of response to treatment with cyclosporine (CYA) plus prednisone in seven episodes of pure red cell aplasia (PRCA) in four patients with B cell chronic lymphocytic leukemia (CLL). Fourteen episodes of PRCA occurred in four patients with CLL. Eleven episodes were treated with conventional therapies which included an alkylating agent and prednisone. Four episodes that failed to respond to conventional therapies and an additional three episodes were treated with CYA and prednisone. Six of the seven episodes, including three of four which had failed conventional therapies, responded to CYA plus prednisone compared with six of eleven episodes treated with conventional therapies. Response to CYA and prednisone occurred without a reduction in leukemic mass. In contrast, PRCA remission did not occur until after leukemic mass reduction in three of four patients treated successfully with conventional therapies. Time to response was shorter (14 +/- 3 days) with CYA plus prednisone than with conventional therapies (154 +/- 97 days) in three of four patients. These results indicate that CYA plus prednisone is an effective therapy for the induction of remission from PRCA in patients with CLL.

摘要

我们描述了4例B细胞慢性淋巴细胞白血病(CLL)患者的7次纯红细胞再生障碍性贫血(PRCA)发作对环孢素(CYA)加泼尼松治疗的反应特征。4例CLL患者共发生14次PRCA发作。11次发作采用包括烷化剂和泼尼松在内的传统疗法治疗。4次对传统疗法无反应的发作以及另外3次发作采用CYA和泼尼松治疗。7次发作中的6次,包括4次中3次对传统疗法无效的发作,对CYA加泼尼松有反应,而11次采用传统疗法治疗的发作中有6次有反应。对CYA和泼尼松的反应发生时白血病细胞数量并未减少。相比之下,4例成功接受传统疗法治疗的患者中有3例直到白血病细胞数量减少后PRCA才缓解。4例患者中有3例使用CYA加泼尼松的反应时间(14±3天)比使用传统疗法(154±97天)短。这些结果表明,CYA加泼尼松是诱导CLL患者PRCA缓解的有效疗法。

相似文献

1
Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia.环孢素和泼尼松治疗慢性淋巴细胞白血病患者的纯红细胞再生障碍性贫血
Am J Hematol. 1992 Sep;41(1):5-12. doi: 10.1002/ajh.2830410103.
2
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.伊布替尼治疗慢性淋巴细胞白血病期间发生纯红细胞再生障碍。
J Oncol Pharm Pract. 2023 Dec;29(8):2031-2036. doi: 10.1177/10781552231189192. Epub 2023 Jul 30.
3
Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.静脉注射免疫球蛋白浓缩物成功治疗与B细胞慢性淋巴细胞白血病相关的复发性纯红细胞再生障碍性贫血。
Ann Ital Med Int. 2002 Jan-Mar;17(1):47-50.
4
[Pure red cell aplasia, associated with chronic lymphoid leukemia, successfully treated with closorine].[与慢性淋巴细胞白血病相关的纯红细胞再生障碍性贫血,用氯索林成功治疗]
Orv Hetil. 1997 Nov 9;138(45):2883-7.
5
Pure red-cell aplasia in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者的纯红细胞再生障碍
Medicine (Baltimore). 1986 Sep;65(5):339-51. doi: 10.1097/00005792-198609000-00006.
6
Cyclosporin-A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukemia.环孢素A治疗1例B细胞慢性淋巴细胞白血病合并纯红细胞再生障碍性贫血患者
Eur J Haematol. 1989 Mar;42(3):303-7. doi: 10.1111/j.1600-0609.1989.tb00117.x.
7
Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia.环孢素A治疗慢性淋巴细胞白血病患者的纯红细胞再生障碍性贫血
Am J Hematol. 1987 Oct;26(2):179-89. doi: 10.1002/ajh.2830260209.
8
Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.自身免疫性疾病与慢性淋巴细胞白血病:自身免疫性溶血性贫血、纯红细胞再生障碍性贫血及自身免疫性血小板减少症。
Semin Oncol. 1998 Feb;25(1):80-97.
9
Cyclosporin therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia.环孢素治疗慢性淋巴细胞白血病患者的纯红细胞再生障碍性贫血
Am J Hematol. 1994 Feb;45(2):192. doi: 10.1002/ajh.2830450221.
10
Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.利妥昔单抗治疗B细胞淋巴增殖性疾病所致纯红细胞再生障碍:2例报告并文献复习
Leuk Res. 2006 Jan;30(1):109-14. doi: 10.1016/j.leukres.2005.05.017. Epub 2005 Jul 25.

引用本文的文献

1
Autoimmune complications in chronic lymphocytic leukaemia (CLL).慢性淋巴细胞白血病(CLL)的自身免疫并发症。
Best Pract Res Clin Haematol. 2010 Mar;23(1):47-59. doi: 10.1016/j.beha.2010.01.004.
2
Management of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的管理
Drugs Aging. 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002.
3
A case of pure red cell aplasia: follow-up on different immunosuppressive regimens.
Clin Investig. 1994 Dec;72(12):1051-5. doi: 10.1007/BF00577754.
4
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.环孢素。对其药效学和药代动力学特性以及在免疫调节紊乱中的治疗应用的综述。
Drugs. 1993 Jun;45(6):953-1040. doi: 10.2165/00003495-199345060-00007.
5
Current approaches to the treatment and management of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的当前治疗与管理方法
Drugs. 1994;47 Suppl 6:1-9. doi: 10.2165/00003495-199400476-00003.